Early research (Phase 1)Study completedNCT01301807
What this trial is testing
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
Who this might be right for
Non-Secretory Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 63